The International Holding Company announced its investment of 187 million dirhams in the Oxford Nanopore company, which specializes in DNA sequencing technology.
Global Holding said in a statement to the Abu Dhabi Securities Exchange today, Tuesday, that it will acquire a stake in the British company in exchange for this investment.
Oxford Nanopore will allocate this funding to expand its innovation efforts and expand its commercial and manufacturing operations.
It is noteworthy that the British company is currently investing in expanding the scope of the Lumpur examination for the Coronavirus, which is a fast and scalable examination dedicated to the detection of the SARS-Cove 2 virus. Designed for use across corporate devices.
After being approved by the UK Medicines and Healthcare Products Regulatory Agency in the United Kingdom, the Lumpur test has become approved for use in the European market, as it is used in laboratory diagnostic procedures to detect the virus SARS-CoV-2, based on GridION device.
The company is currently submitting other requests for regulatory approvals across other countries, including for a license to use emergency situations in the United States and the United Arab Emirates.
p>
It is worth noting that the British company recently increased its capital to 84.4 million pounds sterling to expand innovation and accelerate trade and manufacturing.
